Patent · US Active

Pentaaza macrocyclic ring complexes possessing oral bioavailability

US11066433B2 · kind B2 · utility

5Cited by

24References

15Claims

0Family size

Assignee

Galera Labs, LLC · US

Inventors

Jeffery L. KEENE · Chesterfield, US
Otto F. SCHALL · Creve Coeur, US
Dennis P. Riley · Chesterfield, US

Key dates

Filing date	Mar 9, 2020
Grant date	Jul 20, 2021
Priority date	—
Expiry date	Mar 9, 2040

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P29/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Aspects of the present disclosure relate to compounds which have enhanced oral bioavailability. A transition metal complex includes a transition metal coordinated by a macrocycle comprising the pentaaza 15-membered macrocyclic ring corresponding to Formula A and two axial ligands having the formula —OC(O)X1.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.